Microbix Biosystems Inc.
MBXBF
$0.2992
$0.00511.73%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -66.08% | -78.32% | 131.49% | 1,097.44% | 288.55% |
| Total Depreciation and Amortization | 1.67% | 111.05% | 37.66% | 34.08% | 58.10% |
| Total Amortization of Deferred Charges | -- | -75.43% | -- | -- | -- |
| Total Other Non-Cash Items | -5.41% | 109.00% | -58.44% | 14.14% | 21.51% |
| Change in Net Operating Assets | 57.13% | 66.04% | -74.20% | 85.20% | -2,009.80% |
| Cash from Operations | -42.46% | 151.73% | -35.35% | 179.75% | 287.15% |
| Capital Expenditure | -437.41% | -91.47% | -234.17% | -16.10% | 72.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -437.41% | -91.47% | -357.65% | -16.10% | 72.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.14% | 0.00% | -312.13% | 1.48% | 8.60% |
| Issuance of Common Stock | -- | -- | -- | 310.69% | -- |
| Repurchase of Common Stock | -872.05% | -67.20% | 2.11% | 1.25% | 85.42% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -289.95% | -64.32% | -99.71% | -112.34% | 42.08% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -93.00% | 108.43% | -103.74% | 112.86% | 210.43% |
